Literature DB >> 34135382

Radiofrequency EMF irradiation effects on pre-B lymphocytes undergoing somatic recombination.

Elena Ioniţă1,2, Aurelian Marcu3, Mihaela Temelie1, Diana Savu1, Mihai Şerbănescu3, Mihai Ciubotaru4,5.   

Abstract

Intense electromagnetic fields (EMFs) induce DNA double stranded breaks (DSBs) in exposed lymphocytes.We study developing pre-B lymphocytes following V(D)J recombination at their Immunoglobulin light chain loci (IgL). Recombination physiologically induces DNA DSBs, and we tested if low doses of EMF irradiation affect this developmental stage. Recombining pre-B cells, were exposed for 48 h to low intensity EMFs (maximal radiative power density flux S of 9.5 µW/cm2 and electric field intensity 3 V/m) from waves of frequencies ranging from 720 to 1224 MHz. Irradiated pre-B cells show decreased levels of recombination, reduction which is dependent upon the power dose and most remarkably upon the frequency of the applied EMF. Although 50% recombination reduction cannot be obtained even for an S of 9.5 µW/cm2 in cells irradiated at 720 MHz, such an effect is reached in cells exposed to only 0.45 µW/cm2 power with 950 and 1000 MHz waves. A maximal four-fold recombination reduction was measured in cells exposed to 1000 MHz waves with S from 0.2 to 4.5 µW/cm2 displaying normal levels of γH2AX phosphorylated histone. Our findings show that developing B cells exposure to low intensity EMFs can affect the levels of production and diversity of their antibodies repertoire.

Entities:  

Year:  2021        PMID: 34135382     DOI: 10.1038/s41598-021-91790-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  44 in total

Review 1.  Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling.

Authors:  Sebastian Herzog; Michael Reth; Hassan Jumaa
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

2.  Stat5a/b are essential for normal lymphoid development and differentiation.

Authors:  Zhengju Yao; Yongzhi Cui; Wendy T Watford; Jay H Bream; Kunihiro Yamaoka; Bruce D Hissong; Denise Li; Scott K Durum; Qiong Jiang; Avinash Bhandoola; Lothar Hennighausen; John J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

Review 3.  V(D)J recombination: mechanisms of initiation.

Authors:  David G Schatz; Patrick C Swanson
Journal:  Annu Rev Genet       Date:  2011-08-19       Impact factor: 16.830

4.  Crystal structure of the V(D)J recombinase RAG1-RAG2.

Authors:  Min-Sung Kim; Mikalai Lapkouski; Wei Yang; Martin Gellert
Journal:  Nature       Date:  2015-02-18       Impact factor: 49.962

Review 5.  JAK and STAT signaling molecules in immunoregulation and immune-mediated disease.

Authors:  John J O'Shea; Robert Plenge
Journal:  Immunity       Date:  2012-04-20       Impact factor: 31.745

Review 6.  Recombination centres and the orchestration of V(D)J recombination.

Authors:  David G Schatz; Yanhong Ji
Journal:  Nat Rev Immunol       Date:  2011-03-11       Impact factor: 53.106

7.  A unique function for cyclin D3 in early B cell development.

Authors:  A Byron Cooper; Catherine M Sawai; Ewa Sicinska; Sarah E Powers; Piotr Sicinski; Marcus R Clark; Iannis Aifantis
Journal:  Nat Immunol       Date:  2006-04-02       Impact factor: 25.606

8.  Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members.

Authors:  Qiong Jiang; Wen Qing Li; Robert R Hofmeister; Howard A Young; David R Hodge; Jonathan R Keller; Annette R Khaled; Scott K Durum
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

9.  STAT5 activation underlies IL7 receptor-dependent B cell development.

Authors:  Christine A Goetz; Ian R Harmon; Jennifer J O'Neil; Matthew A Burchill; Michael A Farrar
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

10.  Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.

Authors:  J J Peschon; P J Morrissey; K H Grabstein; F J Ramsdell; E Maraskovsky; B C Gliniak; L S Park; S F Ziegler; D E Williams; C B Ware; J D Meyer; B L Davison
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.